Memphis Pharmaceuticals (MPCI)

Egypt
Currency in EGP
81.35
-0.25(-0.31%)
Closed·
MPCI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
81.1484.49
52 wk Range
26.5584.98
Key Statistics
Edit
Bid/Ask
81.97 / 83.50
Prev. Close
81.6
Open
82.8
Day's Range
81.14-84.49
52 wk Range
26.55-84.98
Volume
352.71K
Average Volume (3m)
190.69K
1-Year Change
188.07%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MPCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Memphis Pharmaceuticals Company Profile

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms. The company was founded in 1940 and is based in Cairo, Egypt. Memphis Pharmaceuticals & Chemical Industries is a subsidiary of HoldiPharma.

Employees
144
Market
Egypt

Compare MPCI to Peers and Sector

Metrics to compare
MPCI
Peers
Sector
Relationship
P/E Ratio
4.6x9.6x−0.5x
PEG Ratio
−0.080.020.00
Price/Book
2.8x1.8x2.6x
Price / LTM Sales
1.4x1.2x3.1x
Upside (Analyst Target)
-4.6%45.7%
Fair Value Upside
Unlock14.6%5.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 17.62%
Dividend Yield
4.92%
Annualized payout
4.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 25, 2025
EPS / Forecast
4.73 / --
Revenue / Forecast
309.36M / --
EPS Revisions
Last 90 days

MPCI Income Statement

People Also Watch

57.76
NIPH
-2.47%
485.81
AXPH
-5.53%
33.99
ARCC
+0.35%
292.04
EDFM
0.00%

FAQ

What Is the Memphis Pharma (MPCI) Stock Price Today?

The Memphis Pharma stock price today is 81.35

What Stock Exchange Does Memphis Pharma Trade On?

Memphis Pharma is listed and trades on the Egypt Stock Exchange stock exchange.

What Is the Stock Symbol for Memphis Pharma?

The stock symbol for Memphis Pharma is "MPCI."

Does Memphis Pharma Pay Dividends? What’s The Current Dividend Yield?

The Memphis Pharma dividend yield is 4.92%.

What Is the Memphis Pharma Market Cap?

As of today, Memphis Pharma market cap is 1.85B.

What Is Memphis Pharma's Earnings Per Share (TTM)?

The Memphis Pharma EPS (TTM) is 17.62.

From a Technical Analysis Perspective, Is MPCI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Memphis Pharma Stock Split?

Memphis Pharma has split 2 times.

How Many Employees Does Memphis Pharma Have?

Memphis Pharma has 144 employees.

What is the current trading status of Memphis Pharma (MPCI)?

As of Jul 12, 2025, Memphis Pharma (MPCI) is trading at a price of 81.35, with a previous close of 81.60. The stock has fluctuated within a day range of 81.14 to 84.49, while its 52-week range spans from 26.55 to 84.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.